BDX
Price
$207.90
Change
+$1.40 (+0.68%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
58.83B
5 days until earnings call
Intraday BUY SELL Signals
PDEX
Price
$39.06
Change
-$0.97 (-2.42%)
Updated
Feb 4, 03:00 PM (EDT)
Capitalization
128.18M
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs PDEX

Header iconBDX vs PDEX Comparison
Open Charts BDX vs PDEXBanner chart's image
Becton Dickinson and
Price$207.90
Change+$1.40 (+0.68%)
Volume$17.75K
Capitalization58.83B
Pro-Dex
Price$39.06
Change-$0.97 (-2.42%)
Volume$100
Capitalization128.18M
BDX vs PDEX Comparison Chart in %
BDX
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDX vs. PDEX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and PDEX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BDX: $206.50 vs. PDEX: $40.03)
Brand notoriety: BDX and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDX: 153% vs. PDEX: 135%
Market capitalization -- BDX: $58.83B vs. PDEX: $128.18M
BDX [@Pharmaceuticals: Other] is valued at $58.83B. PDEX’s [@Pharmaceuticals: Other] market capitalization is $128.18M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.76B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDX and PDEX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 3 TA indicator(s) are bullish while PDEX’s TA Score has 4 bullish TA indicator(s).

  • BDX’s TA Score: 3 bullish, 5 bearish.
  • PDEX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PDEX is a better buy in the short-term than BDX.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а +1.52% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -2.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.30%, and the average quarterly price growth was +23.34%.

Reported Earning Dates

BDX is expected to report earnings on Feb 09, 2026.

PDEX is expected to report earnings on Apr 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($58.8B) has a higher market cap than PDEX($128M). BDX has higher P/E ratio than PDEX: BDX (35.48) vs PDEX (11.72). BDX YTD gains are higher at: 6.405 vs. PDEX (4.028). BDX has higher annual earnings (EBITDA): 4.96B vs. PDEX (17.1M). PDEX has less debt than BDX: PDEX (13.8M) vs BDX (19.2B). BDX has higher revenues than PDEX: BDX (21.8B) vs PDEX (70.2M).
BDXPDEXBDX / PDEX
Capitalization58.8B128M45,938%
EBITDA4.96B17.1M28,982%
Gain YTD6.4054.028159%
P/E Ratio35.4811.72303%
Revenue21.8B70.2M31,054%
Total CashN/A10.6M-
Total Debt19.2B13.8M139,130%
FUNDAMENTALS RATINGS
BDX vs PDEX: Fundamental Ratings
BDX
PDEX
OUTLOOK RATING
1..100
6462
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
8030
PRICE GROWTH RATING
1..100
5152
P/E GROWTH RATING
1..100
6986
SEASONALITY SCORE
1..100
n/a22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (22) in the Medical Specialties industry is somewhat better than the same rating for PDEX (69) in the Medical Or Nursing Services industry. This means that BDX’s stock grew somewhat faster than PDEX’s over the last 12 months.

PDEX's Profit vs Risk Rating (82) in the Medical Or Nursing Services industry is in the same range as BDX (100) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to BDX’s over the last 12 months.

PDEX's SMR Rating (30) in the Medical Or Nursing Services industry is somewhat better than the same rating for BDX (80) in the Medical Specialties industry. This means that PDEX’s stock grew somewhat faster than BDX’s over the last 12 months.

BDX's Price Growth Rating (51) in the Medical Specialties industry is in the same range as PDEX (52) in the Medical Or Nursing Services industry. This means that BDX’s stock grew similarly to PDEX’s over the last 12 months.

BDX's P/E Growth Rating (69) in the Medical Specialties industry is in the same range as PDEX (86) in the Medical Or Nursing Services industry. This means that BDX’s stock grew similarly to PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXPDEX
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
42%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
40%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWJV43.420.82
+1.92%
iShares MSCI Japan Value ETF
LFDR188.87N/A
N/A
LifeX Durable Income ETF
APRZ37.95N/A
N/A
TrueShares Structured Outcome April ETF
KJUL32.39-0.04
-0.12%
Innovator Russell 2000 Pwr Bffr ETF™ Jul
IBB173.80-0.34
-0.20%
iShares Biotechnology ETF

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TMO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+2.27%
TMO - BDX
50%
Loosely correlated
-2.01%
TFX - BDX
49%
Loosely correlated
-0.96%
CNMD - BDX
48%
Loosely correlated
-1.07%
RVTY - BDX
45%
Loosely correlated
-5.57%
STE - BDX
44%
Loosely correlated
-0.97%
More

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and LMAT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and LMAT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-0.07%
LMAT - PDEX
30%
Poorly correlated
+1.30%
LDXHF - PDEX
25%
Poorly correlated
N/A
TCMD - PDEX
24%
Poorly correlated
-1.78%
PRE - PDEX
23%
Poorly correlated
+0.31%
BDX - PDEX
23%
Poorly correlated
+2.27%
More